Clinical trial
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication…
NCT00135122 · Sorlandet Hospital HF, Other · Completed
Key facts
| NCT number | NCT00135122 |
|---|---|
| Title | Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache |
| Official title | Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy |
| Lead sponsor | Sorlandet Hospital HF, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Headache |
| Intervention type | Drug |
| Interventions | prednisolone |
| Enrollment | 100 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Aug 25, 2005 |
| Last update posted | Sep 12, 2008 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: